ABCG2 and melanoma: E2F1 promotes chemoresistance by inducing the expression of ABC transporter ABCG2 [114] and confers anticancer drug resistance by activating ABC transporter family members (ABCA2 and ABCA5) and Bcl-2 in malignant melanoma cells [115].